MS

Mitali Singha Roy

Active Director Director DIN 09161603
DIN 09161603 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mitali Singha Roy

Data last updated:

Mitali Singha Roy is a Director at Rtr Meditreat Private Limited (since 2021). The company operates in Healthcare.

DIN 09161603
Primary Designation Director
Industry Healthcare
First Appointment 29 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rtr Meditreat Private Limited U85100WB2021PTC244891
Director29 Apr 20212021Active

Board colleagues of Mitali Singha Roy

NameDINCompanyDesignation
Sathi Nandy09161551Rtr Meditreat Private LimitedDirector
Tushar Das09161552Rtr Meditreat Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rtr Meditreat Private Limited
Premium access

Shareholding and investment profile for Mitali Singha Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitali Singha Roy

Mitali Singha Roy currently holds 1 directorship: Rtr Meditreat Private Limited (Director, since 29 Apr 2021).

Mitali Singha Roy was first appointed on 29 Apr 2021 as Director at Rtr Meditreat Private Limited.

The current boards of Mitali Singha Roy's companies include Sathi Nandy (Rtr Meditreat Private Limited), Tushar Das (Rtr Meditreat Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available